Voyager Therapeutics, Inc. - VYGR

Ownership (Schedule 13D / 13G) · latest 50 filings · Back to all files
Visible: 0
Filed Form Reporting person Percent Shares SEC
Aug 14, 2026 SCHEDULE 13G/A Armistice Capital, LLC 5.58% 3,436,000 View
Aug 14, 2026 SCHEDULE 13G/A Steven Boyd 5.58% 3,436,000 View
Jul 31, 2026 SCHEDULE 13G/A Integrated Core Strategies (US) LLC 7.3% 4,437,293 View
Jul 31, 2026 SCHEDULE 13G/A Millennium Management LLC 7.4% 4,442,951 View
Jul 31, 2026 SCHEDULE 13G/A Millennium Group Management LLC 7.4% 4,442,951 View
Jul 31, 2026 SCHEDULE 13G/A Israel A. Englander 7.4% 4,442,951 View
May 15, 2026 SCHEDULE 13G/A EcoR1 Capital, LLC 0.0% 0 View
May 15, 2026 SCHEDULE 13G/A Oleg Nodelman 0.0% 0 View
May 15, 2026 SCHEDULE 13G/A EcoR1 Capital Fund Qualified, L.P. 0.0% 0 View
May 15, 2026 SCHEDULE 13G/A Armistice Capital, LLC 5.87% 3,500,000 View
May 15, 2026 SCHEDULE 13G/A Steven Boyd 5.87% 3,500,000 View
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G. Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F). Amendments (/A) can repeat the same holder over time, so rows should not be summed. Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.